Boulot G, Eiselé J L, Bentley G A, Bhat T N, Ward E S, Winter G, Poljak R J
U.R.A. 359 C.N.R.S., Département d'Immunologie, Institut Pasteur, Paris, France.
J Mol Biol. 1990 Jun 20;213(4):617-9. doi: 10.1016/S0022-2836(05)80248-7.
The associated heavy (VH) and light (VL) chain variable domains (Fv) of the monoclonal anti-lysozyme antibody D1.3, secreted from Escherichia coli, have been crystallized in their antigen-bound and free forms. FvD1.3 gives tetragonal crystals, space group P4(1)2(1)2 (or P4(3)2(1)2), with a = 90.6 A, c = 56.4 A. The FvD1.3-lysozyme complex crystallizes in space group C2, with a = 129.2 A, b = 60.8 A, c = 56.9 A and beta = 119.3 degrees. The crystals contain one molecule of Fv or of the Fv-lysozyme complex in their asymmetric units and diffract X-rays to high resolution, making them suitable for X-ray crystallographic studies.
从大肠杆菌分泌的单克隆抗溶菌酶抗体D1.3的相关重链(VH)和轻链(VL)可变结构域(Fv),已分别以与抗原结合及游离的形式结晶。FvD1.3形成四方晶体,空间群为P4(1)2(1)2(或P4(3)2(1)2),a = 90.6 Å,c = 56.4 Å。FvD1.3-溶菌酶复合物结晶于空间群C2中,a = 129.2 Å,b = 60.8 Å,c = 56.9 Å,β = 119.3°。这些晶体在其不对称单元中含有一个Fv分子或Fv-溶菌酶复合物分子,并且能将X射线衍射至高分辨率,使其适用于X射线晶体学研究。